Sierra Oncology, Inc.
SEC CIK 1290149 · SRRA · last insider filing 2022-07-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Orbimed Advisors LLC | Director | filed 2015–2022 |
| Orbimed Capital LLC | Director | filed 2019–2022 |
| Pelzer Robert | Director | filed 2015–2022 |
| Cooper Jeffrey H | Director | filed 2016–2022 |
| Collard Craig A | Director | filed 2020–2022 |
| Allen Andrew R | Director | filed 2017–2022 |
| Dilly Stephen George | Director · CEO and President | filed 2020–2022 |
| Vivo Ventures Fund VII, L.P. | Director | filed 2015–2022 |
| Vivo Ventures VII Affiliates Fund, L.P. | Director | filed 2015–2022 |
| Aggarwal Gaurav | Director | filed 2019–2022 |
| Erbez Georgia | Director | filed 2021–2022 |
| Vivo Ventures VII, LLC | Director | filed 2015–2022 |
| Vivo Opportunity, LLC | Director | filed 2019–2022 |
| Vivo Capital Fund IX, L.P. | Director | filed 2019–2022 |
| Vivo Capital IX, LLC | Director | filed 2019–2022 |
| Orbimed Capital GP VII LLC | Director | filed 2019–2022 |
| Sinclair Andrew | Director | filed 2019–2022 |
| Ashiya Mona | Director | filed 2019–2022 |
| Orbimed Genesis GP LLC | Director | filed 2022–2022 |
| Oliger Christy J. | Director | filed 2021–2022 |
| Vivo Opportunity Fund Holdings, L.P. | Director | filed 2022–2022 |
| Richardson Joshua | Director | filed 2019–2022 |
| Glover Nicholas | Director · CEO and President | filed 2015–2020 |
| Orbimed Global Healthcare GP LLC | Director | filed 2019–2020 |
| Onetto Nicole | Director | filed 2015–2019 |
| Parfet Donald R | Director · Chairman of the Board | filed 2015–2019 |
| Nguyen Tran | Director | filed 2016–2019 |
| Estes Daniel | Director | filed 2017–2019 |
| Topper James N | Director | filed 2015–2017 |
| Isaly Samuel D | Director | filed 2015–2015 |
| Thompson Peter A. | Director | filed 2015–2015 |
| Cha Albert | Director | filed 2015–2015 |
| Orbimed Private Investments V, LP | Director | filed 2015–2015 |
| Vitangcol Alvin | Director | filed 2015–2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thomson Mary Christina | General Counsel, CCO & Sec'y | filed 2021–2022 |
| Jagpal Sukhi | Chief Financial Officer | filed 2015–2022 |
| Klencke Barbara | Chief Medical Officer | filed 2015–2022 |
| Turner William D. | Chief Reg & Tech Ops Officer | filed 2020–2022 |
| Norrett Kevin | Chief Business Officer | filed 2020–2022 |
| Kowalski Mark | Chief, Research & Early Dev | filed 2017–2022 |
| Thomson Christina | General Counsel | filed 2020–2021 |
| Hassig Christian | Chief Scientific Officer | filed 2018–2019 |
| You Angie | Chief Bus. & Strat. Officer | filed 2015–2018 |
| Chapman Wendy | SVP Clinical Operations | filed 2015–2016 |
| Messmann Richard A | Chief Medical Officer | filed 2015–2016 |
| Lovejoy Chandra D | SVP of Reg. Affairs & Quality | filed 2015–2016 |
| Rodigueza Wendi | Chief Scientific Officer | filed 2015–2016 |
| Anderson Keith Edward | SVP, Technical Operations | filed 2015–2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.